文献速递免疫规划传染病防控与疫情报告

瑞士急性中耳炎患者接种肺炎球菌结合疫苗前后肺炎球菌携带及血清型变化

Pneumococcal carriage and serotype variation before and after introduction of pneumococcal conjugate vaccines in patients with acute otitis media in Switzerland.
PubMed 文献 · Vaccine · 2017-03-06

该研究分析了2004至2015年瑞士急性中耳炎门诊患者中七价和13价肺炎球菌结合疫苗(PCV7和PCV13)对肺炎球菌携带及血清型分布的影响。共纳入3300份鼻咽拭子和620份中耳液样本,结果显示PCV13时代肺炎球菌携带率降低(调整OR 0.65,95%CI 0.45-0.94),疫苗血清型减少但血清型3例外,非PCV13血清型11、15和23群增加。

要点

  • PCV13时代鼻咽拭子肺炎球菌携带率较其他时代降低(调整OR 0.65,95%CI 0.45-0.94)。
  • 结合疫苗引入后疫苗血清型显著减少,但血清型3例外。
  • 非PCV13血清型11、15和23群在鼻咽拭子和中耳液中均增加。

核心结论

  • 肺炎球菌携带及血清型流行病学的显著变化提示结合疫苗对瑞士肺炎球菌性急性中耳炎有影响。

研究设计与样本

  • 瑞士急性中耳炎门诊患者监测研究,纳入2004至2015年所有年龄患者,覆盖PCV7前、PCV7和PCV13三个疫苗接种时代。
  • 共纳入3300份鼻咽拭子和620份中耳液样本,进行培养鉴定肺炎球菌,采用logistic回归分析调整社会人口学因素后评估疫苗时代与肺炎球菌携带的关联。

主要发现

  • 急性中耳炎患者样本数随疫苗接种时代下降,PCV13时代肺炎球菌分离频率低于其他两个时代。
  • PCV13疫苗接种时代与鼻咽拭子肺炎球菌携带减少独立相关(调整OR 0.65,95%CI 0.45-0.94)。
  • 结合疫苗引入后疫苗血清型显著减少,但血清型3例外。
  • 非PCV13血清型中,血清群11、15和23在鼻咽拭子和中耳液中均观察到特别增加。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute otitis media (AOM) is an important cause for antibiotic prescription within the paediatric population and Streptococcus pneumoniae is a major pathogen associated with AOM episodes. This study aimed at analysing the influence of the heptavalent and 13-valent pneumococcal conjugate vaccines (PCV7 and PCV13) on pneumococcal carriage and serotype distribution in AOM. METHODS: Nasopharyngeal swabs (NPS) and middle ear fluid (MEF) were collected within a Swiss surveillance study of outpatients from all ages with AOM between 2004 and 2015, covering three vaccination eras (pre-PCV7, PCV7 and PCV13). Samples were cultured for pneumococcal identification, and the association of vaccine era with pneumococcal carriage was investigated by logistic regression analysis adjusting for sociodemographic factors. FINDINGS: In total, 3300 NPS and 620 MEF were included in this study. The number of samples from patients with AOM dropped over vaccination eras and S. pneumoniae was less frequently isolated in the PCV13 era as compared to the other two eras. The latest (PCV13) vaccination era was independently associated with a reduced pneumococcal carriage within NPS (adjusted odds ratio 0.65, 95%-CI 0.45-0.94). Investigating serotype epidemiology, vaccine serotypes decreased significantly after the conjugate vaccine introductions with the exception of serotype 3. Within the non-PCV13 serotypes, a particular increase of serogroups 11, 15 and 23 was observed in both NPS and MEF. CONCLUSION: A substantial change in pneumococcal carriage and serotype epidemiology suggests an impact of the conjugate vaccines on pneumococcal AOM in Switzerland.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Allemann A, Frey PM, Brugger SD, et al. Pneumococcal carriage and serotype variation before and after introduction of pneumococcal conjugate vaccines in patients with acute otitis media in Switzerland. Vaccine. 2017. PMID: 28279564. doi:10.1016/j.vaccine.2017.02.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。